Bassem Maximos, MD
Obstetrics & Gynecology · League City, TXNPI 1063600013
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (57.7%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by Biogen at 54.0% of the total. 2025 is the largest year on record at $66,783, 4.8 times the $13,902 reported in 2019. Among obstetrics & gynecology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 392 payments — averaging $554.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$117K
- Sage Therapeutics, LLC$61K
- Evofem Biosciences, Inc.$30K
- Intuitive Surgical$5K
- Sumitomo Pharma America, Inc.$2K
- AbbVie$727
- plus $2K from 27 others
Across 403 payments — averaging $6344.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sage Therapeutics, LLC$548K
- Janssen Research & Development, LLC$449K
- GSK$390K
- Pfizer$332K
- Evofem Biosciences, Inc.$283K
- Davol Inc.$146K
- plus $409K from 8 others
What the payments were for
- Consulting fees$43,83220%
- Speaking & faculty fees$125,39358%
- Travel & lodging$38,91018%
- Food & beverage$7,5923%
- Education$1,5911%
- Gifts$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 106 | $117,350 |
| Sage Therapeutics, LLC | 96 | $60,786 |
| Evofem Biosciences, Inc. | 54 | $29,868 |
| Intuitive Surgical | 15 | $5,261 |
| Sumitomo Pharma America, Inc. | 4 | $1,609 |
| AbbVie(2 entities) | 45 | $727 |
| Astellas Pharma US Inc | 11 | $318 |
| Exeltis, USA Inc. | 9 | $201 |
| Hologic Sales And Service, LLC | 7 | $153 |
| Johnson & Johnson | 6 | $152 |
| Mayne Pharma Commercial LLC | 5 | $140 |
| Agile Therapeutics, Inc. | 5 | $96 |
| Bayer | 3 | $71 |
| Innovation Technologies Inc | 2 | $53 |
| Avion Pharmaceuticals | 3 | $49 |
| Davol Inc. | 1 | $47 |
| Medtronic | 1 | $47 |
| Myovant Sciences Inc. | 2 | $47 |
| Shield Therapeutics Inc | 2 | $47 |
| Organon | 2 | $45 |
| Baxter Healthcare | 1 | $43 |
| Medicem Inc. | 1 | $26 |
| Optumhealth Care Solutions, LLC | 1 | $21 |
| Aspira Women's Health Inc | 1 | $21 |
| Zyla Life Sciences, Inc. | 1 | $20 |
| Mission Pharmacal Company | 1 | $18 |
| Millicent US Inc | 1 | $18 |
| Exact Sciences | 1 | $18 |
| Mylan Pharmaceuticals Inc. | 1 | $18 |
| Ascend Therapeutics US, LLC | 1 | $18 |
| Therapeuticsmd, Inc. | 1 | $17 |
| Merck | 1 | $17 |
| Coopersurgical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Zurzuvae$108,483
- ZULRESSO$38,523
- Phexxi$29,077
- Da Vinci Surgical System$3,538
- MYFEMBREE$1,609
- DAVINCI XI$1,500
- Orilissa$110
How this compares
$217,332 in reported general payments places this provider in the 95th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 15 | $307 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in League City
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
- Henry Garza IiiSan Antonio$258K
- Rene LunaMcAllen$257K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.